Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zenas BioPharma granted 51,075 restricted stock units to newly hired employees as inducement awards under Nasdaq Listing Rule 5635(c)(4). The RSUs vest in four equal annual installments starting May 15, 2027, contingent on continued service.
Key figures
- Rsus granted
- 51075
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.